Inamrinone
Back to searchMolecule Structure
Scientific Name
Inamrinone
Description of the Drug
Amrinone is a positive inotropic agent and phosphodiesterase inhibitor used in the management of treatment of congestive heart failure.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01427
http://www.drugbank.ca/drugs/DB01427
Brand Name(s)
Inocor
Company Owner(s)
Baxter Healthcare Corp Anesthesia Critical Care, Hikma Pharmaceuticals Usa Inc, Hospira Inc, Sanofi Aventis Us Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Phosphodiesterase 3A | SINGLE PROTEIN | INHIBITOR | CHEMBL241 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL44012 | |
| PharmGKB | PA164746803 | |
| Human Metabolome Database | HMDB0015496 | |
| DrugBank | DB01427 | |
| PubChem: Thomson Pharma | 15322199 | |
| PubChem | 3698 | |
| Mcule | MCULE-2781267039 | |
| LINCS | LSM-6600 | |
| Nikkaji | J17.949C | |
| BindingDB | 34651 | |
| EPA CompTox Dashboard | DTXSID9022603 | |
| DrugCentral | 201 | |
| Brenda | 13050 | |
| ChemicalBook | CB3774164 | |
| Guide to Pharmacology | 7202 | |
| rxnorm | INAMRINONE LACTATE | INAMRINONE |
| PubChem: Drugs of the Future | 12013242 | |
| ChEBI | 2686 | |
| ZINC | ZINC000008673078 |
